Merck & Co Company News

BCS Wealth Management Boosts Position in Merck & Co., Inc. $MRK - MarketBeat

BCS Wealth Management Boosts Position in Merck & Co., Inc. $MRK MarketBeat

How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - International Consortium of Investigative Journalists - ICIJ

How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide International Consortium of Investigative Journalists - ICIJ

Is Merck & Co. (NYSE:MRK) Driving Growth In The Russell 1000 Index? - Kalkine Media

Is Merck & Co. (NYSE:MRK) Driving Growth In The Russell 1000 Index? Kalkine Media

Our Q4 and full-year 2025 financial results - Merck.com

Our Q4 and full-year 2025 financial results Merck.com

Top 12 Pharma Companies: Eli Lilly Shoots To The Top, Merck Tumbles - Citeline News & Insights

Top 12 Pharma Companies: Eli Lilly Shoots To The Top, Merck Tumbles Citeline News & Insights

Merck & Co. Inc. stock (US58933Y1055): Is its oncology dominance strong enough to unlock new upside? - AD HOC NEWS

Merck & Co. Inc. stock (US58933Y1055): Is its oncology dominance strong enough to unlock new upside? AD HOC NEWS

Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition - CHEManager.

Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition CHEManager.

Massachusetts Financial Services Co. MA Sells 3,132,999 Shares of Merck & Co., Inc. $MRK - MarketBeat

Massachusetts Financial Services Co. MA Sells 3,132,999 Shares of Merck & Co., Inc. $MRK MarketBeat

Merck & Co., Inc. stock (US58933Y1055): Is Keytruda's dominance strong enough to unlock new upside? - AD HOC NEWS

Merck & Co., Inc. stock (US58933Y1055): Is Keytruda's dominance strong enough to unlock new upside? AD HOC NEWS

Merck & Co., Inc. $MRK Shares Sold by Burney Co. - MarketBeat

Merck & Co., Inc. $MRK Shares Sold by Burney Co. MarketBeat

Merck & Co., Inc. stock (US58933Y1055): Is Keytruda's dominance strong enough to unlock sustained up - AD HOC NEWS

Merck & Co., Inc. stock (US58933Y1055): Is Keytruda's dominance strong enough to unlock sustained up AD HOC NEWS

Merck & Co., Inc. (NYSE:MRK) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Merck & Co., Inc. (NYSE:MRK) Receives Consensus Rating of "Moderate Buy" from Brokerages MarketBeat

Merck & Co., Inc. $MRK Shares Acquired by Norris Perne & French LLP MI - MarketBeat

Merck & Co., Inc. $MRK Shares Acquired by Norris Perne & French LLP MI MarketBeat

Carnegie Investment Counsel Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Carnegie Investment Counsel Grows Stock Position in Merck & Co., Inc. $MRK MarketBeat

Merck & Co., Inc. $MRK Shares Purchased by Choreo LLC - MarketBeat

Merck & Co., Inc. $MRK Shares Purchased by Choreo LLC MarketBeat

U.S. Capital Wealth Advisors LLC Has $6.56 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

U.S. Capital Wealth Advisors LLC Has $6.56 Million Stock Holdings in Merck & Co., Inc. $MRK MarketBeat

Ritholtz Wealth Management Purchases 10,305 Shares of Merck & Co., Inc. $MRK - MarketBeat

Ritholtz Wealth Management Purchases 10,305 Shares of Merck & Co., Inc. $MRK MarketBeat

Robeco Institutional Asset Management B.V. Has $262.94 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Robeco Institutional Asset Management B.V. Has $262.94 Million Position in Merck & Co., Inc. $MRK MarketBeat

Sumitomo Mitsui Trust Group Inc. Has $733.85 Million Stake in Merck & Co., Inc. $MRK - MarketBeat

Sumitomo Mitsui Trust Group Inc. Has $733.85 Million Stake in Merck & Co., Inc. $MRK MarketBeat

Merck & Co., Inc. $MRK Shares Purchased by Roffman Miller Associates Inc. PA - MarketBeat

Merck & Co., Inc. $MRK Shares Purchased by Roffman Miller Associates Inc. PA MarketBeat

The new manufacturing facilities powering our US growth - Merck.com

The new manufacturing facilities powering our US growth Merck.com

Merck to split cancer, specialty drug businesses in leadership shakeup - BioPharma Dive

Merck to split cancer, specialty drug businesses in leadership shakeup BioPharma Dive

Bar Harbor Wealth Management Has $18.11 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Bar Harbor Wealth Management Has $18.11 Million Stock Holdings in Merck & Co., Inc. $MRK MarketBeat

Strong Results Lifted Merck & Co (MRK) in Q4 - Yahoo Finance

Strong Results Lifted Merck & Co (MRK) in Q4 Yahoo Finance

Merck & Co.'s Quarterly Earnings Preview: What You Need to Know - FinancialContent

Merck & Co.'s Quarterly Earnings Preview: What You Need to Know FinancialContent

Jackson Square Capital LLC Acquires Shares of 9,701 Merck & Co., Inc. $MRK - MarketBeat

Jackson Square Capital LLC Acquires Shares of 9,701 Merck & Co., Inc. $MRK MarketBeat

5 ways we’re transforming artificial intelligence into impact - Merck.com

5 ways we’re transforming artificial intelligence into impact Merck.com

Merck & Co., Inc. $MRK Shares Sold by Addenda Capital Inc. - MarketBeat

Merck & Co., Inc. $MRK Shares Sold by Addenda Capital Inc. MarketBeat

Merck & Co., Inc., Announces New Disclosures in Just-Released Corporate Responsibility Report - CSRwire

Merck & Co., Inc., Announces New Disclosures in Just-Released Corporate Responsibility Report CSRwire

Douglas Lane & Associates LLC Has $59.56 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Douglas Lane & Associates LLC Has $59.56 Million Position in Merck & Co., Inc. $MRK MarketBeat

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC

Cardinal Capital Management Inc. Has $32.06 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Cardinal Capital Management Inc. Has $32.06 Million Stock Holdings in Merck & Co., Inc. $MRK MarketBeat

Merck & Co. Inc. (NYSE:MRK) Offers a Durable Dividend Backed by Strong Earnings - ChartMill

Merck & Co. Inc. (NYSE:MRK) Offers a Durable Dividend Backed by Strong Earnings ChartMill

Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace

Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline BioSpace

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) - Business Wire

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Business Wire

Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion - Yahoo Finance

Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion Yahoo Finance

Franklin Street Advisors Inc. NC Grows Position in Merck & Co., Inc. $MRK - MarketBeat

Franklin Street Advisors Inc. NC Grows Position in Merck & Co., Inc. $MRK MarketBeat

Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma

Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma

Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Business Wire

Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. Business Wire

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters